ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,074,935 | +10.8% | 99,565 | +27.4% | 0.00% | 0.0% |
| Q2 2023 | $1,872,195 | +26.6% | 78,171 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $1,478,876 | +26.3% | 78,580 | +6.8% | 0.00% | +100.0% |
| Q4 2022 | $1,170,884 | +296.9% | 73,548 | +308.4% | 0.00% | – |
| Q3 2022 | $295,000 | +13.9% | 18,009 | -2.0% | 0.00% | – |
| Q2 2022 | $259,000 | -22.7% | 18,369 | +1.0% | 0.00% | – |
| Q1 2022 | $335,000 | -22.3% | 18,189 | -1.5% | 0.00% | – |
| Q4 2021 | $431,000 | +36.4% | 18,475 | -2.9% | 0.00% | – |
| Q3 2021 | $316,000 | -38.9% | 19,036 | -10.2% | 0.00% | – |
| Q2 2021 | $517,000 | -12.4% | 21,202 | -7.3% | 0.00% | -100.0% |
| Q1 2021 | $590,000 | -48.8% | 22,874 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $1,153,000 | +19.2% | 21,572 | -7.9% | 0.00% | 0.0% |
| Q3 2020 | $967,000 | -12.1% | 23,434 | +3.2% | 0.00% | 0.0% |
| Q2 2020 | $1,100,000 | -42.6% | 22,703 | -50.0% | 0.00% | -50.0% |
| Q1 2020 | $1,918,000 | +97.5% | 45,416 | +100.2% | 0.00% | +100.0% |
| Q4 2019 | $971,000 | +40.5% | 22,688 | +18.1% | 0.00% | 0.0% |
| Q3 2019 | $691,000 | +8537.5% | 19,209 | +3644.4% | 0.00% | – |
| Q2 2018 | $8,000 | -33.3% | 513 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | -20.0% | 513 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | -21.1% | 513 | 0.0% | 0.00% | – |
| Q3 2017 | $19,000 | +35.7% | 513 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | -17.6% | 513 | +1.8% | 0.00% | – |
| Q1 2017 | $17,000 | +13.3% | 504 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | 0.0% | 504 | +5.9% | 0.00% | – |
| Q3 2016 | $15,000 | +7.1% | 476 | +7.4% | 0.00% | – |
| Q2 2016 | $14,000 | +16.7% | 443 | +2.1% | 0.00% | – |
| Q1 2016 | $12,000 | -14.3% | 434 | +8.0% | 0.00% | – |
| Q4 2015 | $14,000 | +7.7% | 402 | +6.1% | 0.00% | – |
| Q3 2015 | $13,000 | -13.3% | 379 | +8.9% | 0.00% | – |
| Q2 2015 | $15,000 | – | 348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |